Amy Kosranabout 1 year ago
FDA Approves Mirikizumab for Ulcerative Colitis
Mirikizumab (Omvoh) is the first IL-23 inhibitor to be approved in the United States for the treament of moderately to severely active ulcerative colitis.
Source: https://www.medscape.com/viewarticle/997822?src=mbl_msp_android&ref=shareOther commentsSign in to post comments. You don't have an account? Sign up now!
Related posts